首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1722643

抗纤溶药物市场报告（按适应症、剂型、最终用户和地区）2025-2033

Antifibrinolytic Drugs Market Report by Indication, Form, End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024 年全球抗纤溶药物市场规模达 176 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 250 亿美元，2025-2033 年期间的成长率 (CAGR) 为 3.77%。

抗纤溶药物是指用于促进血块形成，以防止纤维蛋白溶解或动脉、静脉阻塞的药物。这些药物抑制纤溶酶原的活化，从而防止纤维蛋白的溶解并维持血块的稳定性。它们用于治疗出血、血管肿瘤和缓解月经过多。它们也用于控制侵入性手术期间或之后的出血。一些常见的抗纤维蛋白溶解药物包括氨甲环酸、抑肽酶、氨基己酸和丝氨酸蛋白酶抑制剂。它们广泛用于治疗口咽、鼻腔、胃肠道和子宫阴道内壁的黏膜出血。因此，它们被广泛应用于医院、诊所、创伤和门诊手术中心。

抗纤溶药物市场趋势：

道路交通事故、创伤和各种出血性疾病发生率的上升是推动市场成长的关键因素之一。此外，抗纤维蛋白溶解药物的广泛采用，以防止月经过多以及心血管和神经外科手术期间的女性失血，也为市场成长提供了推动力。抗纤维蛋白溶解药物对于防止血块溶解和减少失血至关重要。同时，群众健康意识的增强以及对遗传性血管性水肿和血友病可用治疗替代方案的认识也促进了市场的成长。各种技术进步和抗纤溶疗法的日益普及以减少骨科患者输血，是其他促进成长的因素。药厂也正在开发具有增强功效和生物吸收性的创新口服和静脉注射药物。其他因素，包括老年人口的增加和医疗保健基础设施的显着改善，预计将推动市场成长。

本报告回答的关键问题

抗纤溶药物市场有多大？ 2025-2033年全球抗纤溶药物市场的预期成长率为何？
推动全球抗纤溶药物市场发展的关键因素有哪些？
COVID-19 对全球抗纤溶药物市场有何影响？
根据适应症，全球抗纤溶药物市场如何分布？
全球抗纤溶药物市场的主要区域有哪些？
全球抗纤溶药物市场的主要参与者/公司有哪些？

Antifibrinolytic drugs refer to the pharmaceutical medicines used for promoting the formation of blood clots to prevent fibrinolysis or blockage in arteries and veins. These drugs inhibit the activation of plasminogen, thereby preventing the lysis of fibrin and maintaining clot stability. They are used for the treatment of hemorrhages, vascular tumors and providing relief from heavy menstrual bleeding. They are also used for controlling bleeding during or after invasive surgeries. Some commonly available antifibrinolytic drugs include tranexamic acid, aprotinin, aminocaproic acid and serine protease inhibitors. They are widely used for the management of mucosal bleeding in the oropharynx, nose, gastrointestinal (GI) tract and uterine-vaginal linings. As a result, they are extensively used across hospitals, clinics and trauma and ambulatory surgical centers.

Antifibrinolytic Drugs Market Trends:

The rising incidence of road accidents, traumas and various bleeding disorders is one of the key factors driving the growth of the market. Moreover, the widespread adoption of antifibrinolytic drugs to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neurosurgeries is providing a thrust to the market growth. Antifibrinolytic drugs are essential for preventing clot lysis and minimizing blood loss. In line with this, increasing health consciousness and awareness among the masses regarding the available treatment alternatives for hereditary angioedema and hemophilia are also contributing to the growth of the market. Various technological advancements and the increasing utilization of antifibrinolytic therapy to reduce transfusion in orthopedic patients are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing innovative oral and intravenous drug variants with enhanced efficacy and bio-absorbability. Other factors, including the rising geriatric population and significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Indication:

Gynecology
Hereditary Angioedema
Fibrinolytic Response Testing
Surgeries
Others

Breakup by Form:

Oral
Injectable

Breakup by End User:

Hospitals and Clinics
Ambulatory Surgical Centers
Trauma Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ACIC Pharmaceuticals Inc., Akorn Inc., Aurobindo Pharma Limited, Ferring Pharmaceuticals, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Viatris Inc. and Vitruvias Therapeutics Inc.

Key Questions Answered in This Report

1.How big is the antifibrinolytic drugs market?
2.What is the expected growth rate of the global antifibrinolytic drugs market during 2025-2033?
3.What are the key factors driving the global antifibrinolytic drugs market?
4.What has been the impact of COVID-19 on the global antifibrinolytic drugs market?
5.What is the breakup of the global antifibrinolytic drugs market based on the indication?
6.What are the key regions in the global antifibrinolytic drugs market?
7.Who are the key players/companies in the global antifibrinolytic drugs market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Antifibrinolytic Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication

6.1 Gynecology
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Hereditary Angioedema
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Fibrinolytic Response Testing
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Surgeries
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Form

7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Injectable
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Trauma Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 ACIC Pharmaceuticals Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Akorn Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Aurobindo Pharma Limited
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Ferring Pharmaceuticals
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Novartis AG
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Pfizer Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Takeda Pharmaceutical Company Limited
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Viatris Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Vitruvias Therapeutics Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio

简介目录图表

List of Figures

Figure 1: Global: Antifibrinolytic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifibrinolytic Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Antifibrinolytic Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Antifibrinolytic Drugs Market: Breakup by Indication (in %), 2024
Figure 5: Global: Antifibrinolytic Drugs Market: Breakup by Form (in %), 2024
Figure 6: Global: Antifibrinolytic Drugs Market: Breakup by End User (in %), 2024
Figure 7: Global: Antifibrinolytic Drugs Market: Breakup by Region (in %), 2024
Figure 8: Global: Antifibrinolytic Drugs (Gynecology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Antifibrinolytic Drugs (Gynecology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Antifibrinolytic Drugs (Hereditary Angioedema) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Antifibrinolytic Drugs (Fibrinolytic Response Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Antifibrinolytic Drugs (Surgeries) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Antifibrinolytic Drugs (Surgeries) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Antifibrinolytic Drugs (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Antifibrinolytic Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Antifibrinolytic Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Antifibrinolytic Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Antifibrinolytic Drugs (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Antifibrinolytic Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Antifibrinolytic Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Antifibrinolytic Drugs (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Antifibrinolytic Drugs (Trauma Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Antifibrinolytic Drugs (Trauma Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Antifibrinolytic Drugs (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Antifibrinolytic Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: North America: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: North America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: United States: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: United States: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Canada: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Canada: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Asia-Pacific: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Asia-Pacific: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: China: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: China: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Japan: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Japan: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: India: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: India: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: South Korea: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: South Korea: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Australia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Australia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Indonesia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Indonesia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Europe: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Europe: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Germany: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Germany: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: France: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: France: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United Kingdom: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United Kingdom: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Italy: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Italy: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Spain: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Spain: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Russia: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Russia: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Latin America: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Latin America: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Brazil: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Brazil: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Mexico: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Mexico: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Middle East and Africa: Antifibrinolytic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Middle East and Africa: Antifibrinolytic Drugs Market: Breakup by Country (in %), 2024
Figure 78: Middle East and Africa: Antifibrinolytic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Global: Antifibrinolytic Drugs Industry: SWOT Analysis
Figure 80: Global: Antifibrinolytic Drugs Industry: Value Chain Analysis
Figure 81: Global: Antifibrinolytic Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antifibrinolytic Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 3: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Form (in Million USD), 2025-2033
Table 4: Global: Antifibrinolytic Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Antifibrinolytic Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Antifibrinolytic Drugs Market: Competitive Structure
Table 7: Global: Antifibrinolytic Drugs Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

抗纤溶药物市场报告（按适应症、剂型、最终用户和地区）2025-2033

Antifibrinolytic Drugs Market Report by Indication, Form, End User, and Region 2025-2033

抗纤溶药物市场趋势：

本报告回答的关键问题

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球抗纤溶药物市场

第六章：市场区隔：依指标

第七章：市场区隔：依形式

第八章：市场区隔：按最终用户

第九章：市场细分：依地区

第十章：SWOT分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局